Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E BENHAMOU

Showing results (71-80 of 122) with videos related to

Pageof 13
Sort By:
Bulletin De L'Academie Nationale De Medecine|November 1, 1980
[Efficacy of a French hepatitis B vaccine. Results of a multicenter clinical trial, using a placebo, with double-blind randomized administration]J Crosnier, P Jungers, A M Courouce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1986
High-dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: a phase II studyO Hartmann, E Benhamou, F Beaujean, et al.
Journal of Neuro-Oncology|January 1, 1996
Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?S Dupuis-Girod, O Hartmann, E Benhamou, et al.
Bulletin Du Cancer|March 1, 1997
[High-dose chemotherapy in relapse of medulloblastoma in young children]S Dupuis-Girod, O Hartmann, E Benhamou, et al.
Bone Marrow Transplantation|August 1, 1996
Previous conventional chemotherapy is the principal risk factor for immunoglobulin deficiency during the early post-ABMT period in childrenJ Grill, M C Le Deley, D Valteau-Couanet, et al.
Bone Marrow Transplantation|April 1, 1996
Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastomaD Valteau-Couanet, G Vassal, C Pondarré, et al.
Bone Marrow Transplantation|May 9, 2000
Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastomaD Valteau-Couanet, E Benhamou, G Vassal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Prevention of mucositis in bone marrow transplantation: a double blind randomised controlled trial of sucralfateL Castagna, E Benhamou, E Pedraza, et al.
Bone Marrow Transplantation|September 27, 2005
High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacyD Valteau-Couanet, B Fillipini, E Benhamou, et al.
Presse Medicale (Paris, France : 1983)|October 24, 1987
[Veno-occlusive disease of the liver after bone marrow graft. Possible value of fractionation of whole body irradiation]D Baume, J M Cosset, J L Pico, et al.
Pageof 13

Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
Bulletin De L'Academie Nationale De Medecine|November 1, 1980
[Efficacy of a French hepatitis B vaccine. Results of a multicenter clinical trial, using a placebo, with double-blind randomized administration]J Crosnier, P Jungers, A M Courouce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1986
High-dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: a phase II studyO Hartmann, E Benhamou, F Beaujean, et al.
Journal of Neuro-Oncology|January 1, 1996
Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?S Dupuis-Girod, O Hartmann, E Benhamou, et al.
Bulletin Du Cancer|March 1, 1997
[High-dose chemotherapy in relapse of medulloblastoma in young children]S Dupuis-Girod, O Hartmann, E Benhamou, et al.
Bone Marrow Transplantation|August 1, 1996
Previous conventional chemotherapy is the principal risk factor for immunoglobulin deficiency during the early post-ABMT period in childrenJ Grill, M C Le Deley, D Valteau-Couanet, et al.
Bone Marrow Transplantation|April 1, 1996
Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastomaD Valteau-Couanet, G Vassal, C Pondarré, et al.
Bone Marrow Transplantation|May 9, 2000
Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastomaD Valteau-Couanet, E Benhamou, G Vassal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Prevention of mucositis in bone marrow transplantation: a double blind randomised controlled trial of sucralfateL Castagna, E Benhamou, E Pedraza, et al.
Bone Marrow Transplantation|September 27, 2005
High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacyD Valteau-Couanet, B Fillipini, E Benhamou, et al.
Presse Medicale (Paris, France : 1983)|October 24, 1987
[Veno-occlusive disease of the liver after bone marrow graft. Possible value of fractionation of whole body irradiation]D Baume, J M Cosset, J L Pico, et al.
Pageof 13